Skip to main content
Premium Trial:

Request an Annual Quote

Pfizer, Scripps Research Institute Partner on DNA-Encoded Library Tech

NEW YORK (GenomeWeb) – The Scripps Research Institute (TSRI) announced today that it has partnered with Pfizer to develop a novel chemical synthesis technology for creating next-generation DNA-encoded libraries (DELs).

Under the terms of the deal, Pfizer will pay an undisclosed fee to gain access to a chemical synthesis technology developed at TSRI. The two will adapt this technology for use in creating DELs, and choose to expand their joint research to include other technologies enabling DEL-based drug discovery.

Additional terms were not disclosed.

"We hope that this new collaboration will contribute to the creation of novel chemistries that can be used by Pfizer to prepare unique libraries for screening which, together with our parallel medicinal chemistry expertise, will have the potential to help us accelerate the discovery of new medicines for patients," Tony Wood, senior vice president and head of medicinal sciences at Pfizer, said in a statement.

The Scan

Call for a Different Tack

Experts weigh the value of recent experiments testing genetically modified pig kidneys using brain-dead individuals, according to Nature News.

Wastewater Warning

The New York Times reports that wastewater surveillance in some parts of the US point to a possible surge.

Can't Get in the Program

Due to the Northern Ireland protocol dispute, the European Union is preventing UK researchers from joining the Horizon Europe research program, the Times of London reports.

Science Paper on Spatial-Controlled Genome Editing

In Science this week: approach to enable a CRISPR-Cas13a-based system to be used as a cancer therapy.